Belgium· BE-AMP-SAM663051-00
Jeraygo 25 mg
A aprocitentan product containing aprocitentan, registered in Belgium by Idorsia Pharmaceuticals Deutschland. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Aprocitentan is registered in 10 of 19 countries.
Countries holding a registration under ATC C02KN01 (aprocitentan), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Aprocitentan · ATC C02KN01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Aprocitentan
- Manufacturer
- Idorsia Pharmaceuticals Deutschland
- Country
- Belgium (BE)
- ATC code
- C02KN01
- ATC class
- Aprocitentan
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aprocitentan in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandJeraygo 25 mg, FilmtablettenIdorsia Pharmaceuticals Ltd
- CzechiaJERAYGOIdorsia Pharmaceuticals Deutschland GmbH, Lörrach
- FinlandJERAYGOIdorsia Pharmaceuticals Deutschland GmbH
- IrelandJERAYGO 25 mg film-coated tabletsIdorsia Pharmaceuticals Deutschland GmbH
- IcelandJERAYGOIdorsia Pharmaceuticals Deutschland GmbH
- NetherlandsJERAYGO 25 mg filmomhulde tablettenIdorsia Pharmaceuticals Deutschland GmbH
- PolandJeraygoIdorsia Pharmaceuticals Deutschland GmbH
- SwedenJERAYGO 25 mg Filmdragerad tablettIdorsia Pharmaceuticals Deutschland GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jeraygo
- Liechtenstein · Jeraygo
- Norway · Jeraygo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c15ff7a6-cb98-4798-beaa-2a11e2a20849 GET /v1/drugs/c15ff7a6-cb98-4798-beaa-2a11e2a20849?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Jeraygo 25 mg",
"name_fr": "Jeraygo 25 mg",
"name_nl": "Jeraygo 25 mg",
"amp_code": "SAM663051-00",
"strengths": [
"25.0000",
"25.0000",
"45.7000"
],
"pack_count": 2,
"substances": [
"Aprocitentan",
"Lactose Monohydrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Aprocitentan",
"authorisation_numbers": [
"EU/1/24/1818/003",
"EU/1/24/1818/004"
]
}See everything about aprocitentan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.